Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julie Wiese"'
Autor:
Lee P. Lim, Julie Wiese, Alexa B. Schrock, James G. Christensen, Melissa Lynne Johnson, Kevin M. Haigis, Andrew J. Aguirre, Kavita Garg, Hanrong Feng, Viola W. Zhu, Kathryn C. Arbour, Nicole S. Persky, Gregory J. Riely, Joseph O. Jacobson, Shengwu Liu, Tejas Patil, Mark M. Awad, Julien Dilly, Sai-Hong Ignatius Ou, Mark Li, Jason Christiansen, Lynette M. Sholl, Piro Lito, Peter D. Olson, Shannon S. Zhang, J. David Lawson, Jessica J. Y. Lee, Rebecca S. Heist, Kristen E. Lowder, Xiaoping Yang, Laura Waters, David E. Root, Igor I. Rybkin, Lars D. Engstrom, Brian M. Wolpin, Pasi A. Jänne, Yin P Hung
Publikováno v:
N Engl J Med
BACKGROUND: Clinical trials of the KRAS inhibitors adagrasib and sotorasib have shown promising activity in cancers harboring KRAS glycine-to-cysteine amino acid substitutions at codon 12 (KRAS(G12C)). The mechanisms of acquired resistance to these t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36770ea207cb1bf5eda2f1cdf748b5a2
https://pubmed.ncbi.nlm.nih.gov/34375610
https://pubmed.ncbi.nlm.nih.gov/34375610
Autor:
Ryan J Hansen, Steven Horton, Julie Wiese, BellJohn Bibay, E.Lorena Mora-Blanco, Nam-Phuong Nguyen, Lars D Engstrom, David M Briere, Andres Calinisan, Peter Olson, Mark M Awad, Andrew J Aguirre, Jason Christiansen, Christian Hassig, Shailaja Kasibhatla
Publikováno v:
Molecular Cancer Therapeutics. 20:LBA005-LBA005
The recent discovery and clinical validation of KRAS inhibitors (KRASi) has ushered in a new therapeutic approach to directly address the previously undruggable mutant KRAS-driven cancers. Unfortunately, as with other oncogene-directed therapies, acq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c824ed83183d4aa862051a7e6c6206e
https://doi.org/10.1158/1535-7163.targ-21-lba005
https://doi.org/10.1158/1535-7163.targ-21-lba005
Publikováno v:
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 49(4)
The rates of overweight and obesity are high among United States Veterans, necessitating the development of accessible weight reduction interventions.This observational study evaluated the efficacy of a novel home-based telehealth weight loss interve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373cfc7f465cbe2b45d7f097004e155b
https://pubmed.ncbi.nlm.nih.gov/25697133
https://pubmed.ncbi.nlm.nih.gov/25697133